Gene · 2829
NIH grants1,173
NIH grants whose papers are about the gene, through NIH's grant-paper links.
181 to 200 of 1,173
Download this page as JSON| Grant | Title | XCR1 papers | Newest fiscal year |
|---|---|---|---|
| R01CA262506 | Re-wiring PDAC Tumor Immunity Through Dendritic Cells | 1 | 2025 |
| R01CA262555 | Synergized Immune and Tumor Cell Bone Marrow Biomarkers to Predict Recurrence in Triple Negative Breast Cancer | 1 | 2025 |
| R01CA262634 | Gut microbiome-mediated differences within the pre-malignant mammary tissue environment enhance early breast tumor metastasis | 1 | 2025 |
| R01CA271245 | Role of S.aureus in Cutaneous T Cell Lymphoma Pathogenesis | 1 | 2025 |
| R01DE017732 | Diabetes-enhanced Experimental Periodontitis | 1 | 2025 |
| R01DE026644 | Targeting Signaling Vulnerabilities for Oral Cancer Prevention | 1 | 2025 |
| R01DE030691 | New Engineering Strategy for Harnessing Immune System against Head and Neck Cancer | 1 | 2025 |
| R01DE031951 | Engineered Nano-formulations for STING Activation | 1 | 2025 |
| R01DE033909 | Reprogramming the Tumor Immune Microenvironment with Chemokines to Potentiate Immune Oncology Treatments in Oral Cancer | 1 | 2025 |
| R01DK057846 | Modulating pathogenic T cells in Type 1 diabetes | 1 | 2025 |
| R01DK103735 | Clinical & Immunological Study of Treatment Withdrawal in E-Ag Negative Hepatitis B | 1 | 2025 |
| R01DK105129 | MECHANISMS OF CHIEF CELL DEDIFFERENTIATION | 1 | 2025 |
| R01DK107603 | Mucosal Macrophages and Tertiary Lymphoid Structures in IBD | 1 | 2025 |
| R01DK111733 | Mertk Mediated T Cell Suppression in the Pancreatic Islets During Type 1 Diabetes | 1 | 2025 |
| R01DK115217 | Type III interferon Control of Mucosal Immunity | 1 | 2025 |
| R01DK126753 | Role of membrane-associated macrophages in health and inflammation | 1 | 2025 |
| R01DK130111 | Role of adipose mRNA modifications in metabolic disease | 1 | 2025 |
| R01ES025530 | Role of AHR in Dendritic Cells in the Control of CNS Autoimmunity | 1 | 2025 |
| R01ES028802 | Developmental Exposures, Stem Cell Reprogramming, and Breast Cancer Disparities | 1 | 2025 |
| R01GM067153 | Cellular factors maintaining and reversing silencing of bacterial chromatin | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2829/grants?page=10